Your browser doesn't support javascript.
loading
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
Kabashima, Kenji; Furue, Masutaka; Hanifin, Jon M; Pulka, Grazyna; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Nakano, Miwa; Ruzicka, Thomas.
Afiliación
  • Kabashima K; Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: kaba@kuhp.kyoto-u.ac.jp.
  • Furue M; Department of Dermatology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
  • Hanifin JM; Department of Dermatology, Oregon Health and Science University, Portland, Poland.
  • Pulka G; School of Medicine, Jagiellonian University Medical College, Cracow, Poland.
  • Wollenberg A; Department of Dermatology and Allergology, Ludwig-Maximilians-Universität, Munich, Poland.
  • Galus R; Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.
  • Etoh T; Dermatology Department, Tokyo Teishin Hospital, Tokyo, Japan.
  • Mihara R; Clinical Science and Strategy Department, Chugai Pharmaceutical, Tokyo, Japan.
  • Nakano M; Clinical Science and Strategy Department, Chugai Pharmaceutical, Tokyo, Japan.
  • Ruzicka T; Department of Dermatology and Allergology, Ludwig-Maximilians-Universität, Munich, Poland.
J Allergy Clin Immunol ; 142(4): 1121-1130.e7, 2018 10.
Article en En | MEDLINE | ID: mdl-29753033
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prurito / Antialérgicos / Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prurito / Antialérgicos / Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos